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Abstrak  
Tajuk abstrak 
Perbandingan antara kejadian, ciri-ciri radiologi serta hasil pembedahan bagi kumpulan 
Meningioma Asas Tengkorak dan kumpulan Meningioma Bukan Asas Tengkorak di Hospital 
Besar Kuala Lumpur: Kajian retrospektif selama 5 tahun. 
Latar Belakang 
Meningioma adalah pertumbuhan otak yang biasa, didapati di United Kingdom sebanyak  24 
hingga 30% daripada pesakit barah otak menghidapi meningiomas. Di Amerika pula 
dianggarkan sebanyak 2 hingga 3% daripada penduduknya mempunyai meningioma, 
sungguhpun tiada tanda-tanda klinikal pada peringkat awal, dan dilaporkan insiden tahunan 
meningioma sebanyak 2 kes setiap 100,000 orang. Sebanyak 30% meningiomas berada di asas 
tengkorak. Kawasan asas tengkorak ini amat sukar dibedah. Ini kerana meningioma asas 
tengkorak biasanya dekat dengan struktur-struktur penting seperti saraf-saraf kranial penting dan 
pembuluh darah utama. Sungguhpun meningioma biasanya dijumpai di Malaysia, kita masih 
kekurangan data tempatan di Malaysia. 
Prosedur kajian   
Seramai 1149 pesakit yang mempunyai pertumbuhan otak telah dibedah di Hospital Besar Kuala 
Lumpur dari bulan Januari 2010 hingga bulan Disember 2014. Sebanyak 199 pesakit yang 
dibedah didiagnosis meningioma dan memenuhi syarat-syarat kajian kami. Pesakit-pesakit 
tersebut dikategorikan dalam kumpulan meningioma asas tengkorak dan kumpulan meningioma 
bukan asas tengkorak. Data demografi, ciri-ciri tumor serta hasil pembedahan dikaji.  Ujian-ujian 
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seperti ‘Kaplan-Meier survival curve’, ‘univariate and multivariate cox hazard regression’ telah 
dianalisasikan 
 Keputusan:  
Meningioma WHO gred I jauh lebih banyak (n = 194; 97.5%) berbanding dengan WHO gred II, 
dan keputusan ini serasi dengan kajian lain. Kajian kami tiada kes baru meningioma yang 
dikategorikan dalam kumpulan WHO gred III. Kebanyakannya pesakit meningioma adalah 
wanita (67.3%), hanya 32.7% pesakit ialah pesakit lelaki. Kebanyakan pesakit daripada kaum 
Melayu, iaitu seramai 138 orang (69.3%) berbanding dengan kaum lain. 27% daripada semua 
pesakit mempunyai meningioma di asas tengkorak (n = 54) dan majoriti meningioma adalah 
WHO gred I (n = 52, 96.3%). Sebanyak tujuh puluh peratus pesakit dalam kumpulan 
meningioma asas tengkorak adalah perempuan (38 orang). Min umur untuk mereka dikesani 
mempunyai meningioma adalah lebih muda jika dibandingkan dengan kumpulan lain, iaitu 51.7 
tahun (SD 11.01) bagi mereka yang mempunyai meningioma asas tengkorak, manakala min 
umur untuk kumpulan meningioma bukan asas tengkorak adalah 54.1 tahun (SD 9.4).  
Kedua-dua kumpulan meningioma mempunyai pesakit kebanyakannya dalam lingkungan umur 
40-60. Lebih daripada sembilan puluh peratus pesakit kedua-dua kumpulan ini menghadapi 
masalah sakit kepala yang menyebabkan mereka berjumpa doktor. Lima puluh satu pesakit 
dengan meningioma asas tengkorak (94.4%) mempunyai ciri-ciri radiologi otak bengkak; 30 kes 
(55.6%) mempunyai bukti hyperotosi dan 16 pesakit (29.6%) mempunyai kalsifikasi. 
Meningioma asas tengkorak berkaitan dengan hasil pembedahan yang lebih membimbangkan (n 
= 23; 42.6% nilai p <0.01) dan sebanyak 63% meningioma asas tengkorak tidak dapat 
dikeluarkan sepenuhnya.  
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Kajian kami menunjukkan pesakit meningioma asas tengkorak hidup lebih pendek, iaitu selama 
37.6 bulan (SD 20.94) sahaja berbanding dengan 47.8 bulan (SD 18.2) bagi mereka yang 
mempunyai meningioma di luar asas tengkorak dengan nilai-p 0,187. Di samping itu, kajian 
kami mendapati pesakit meningioma asas tengkorak yang mengalami pembedahan adalah 
berisiko 4 kali ganda untuk mati berbanding kumpulan bukan asas tengkorak. Keputusan ini 
diselaraskan dengan jantina, penyakit-penyakit kronik, WHO gred dan tahap meningioma 
dikeluarkan samaada sepenuhnya ataupun tidak, dan didapati nilai p bererti. (HR 4.22; 95% CI 
1,53-11,66; nilai-p 0.005). 
Kesimpulan:  
Pesakit meningioma dapt disembuhkan sepenuhnya jika pertumbuhan dapat dikeluarkan 
sepenuhnya. Meningioma asas tengkorak biasanya susah dikeluarkan sepenuhnya melalui 
pembedahan. Kajian kami mempamerkan hasil pembedahan bagi kumpulan meningioma asas 
tengkorak tidak menggalakkan. Kebanyakan meningioma asas tengkorak juga tidak dapat 
dikeluarkan sepenuhnya melalui pembedahan. Ini amat berbeza dengan pesakit dalam kumpulan 
meningioma bukan asas tengkorak. Selain itu, kajian kami menunjukan bahawa pesakit 
meningioma asas tengkorak berisiko 4 kali ganda untuk mati berbanding dengan pesakit 
meningioma bukan asas tengkorak. Dengan adanya lebih banyak latihan dalam pembedahan asas 
tengkorak serta peningkatan tahap teknologi dalam bidang ini, diharapkan risiko dapat 
dikurangkan demi kebaikan pesakit . Kami ingin mengesyorkan lebih banyak kajian dibuat 
khususnya dalam bidang mengkaji meningioma asas tengkorak, dengan harapan hasil 
pembedahan dapat diperbaiki. 
Kata-kata penting: meningioma, asas tengkorak, WHO, hasil pembedahan.  
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Abstract 
a. Article title 
Comparison on Incidence, Radiological Features and Outcome of Skull Base Versus Non-
skull Base Meningiomas in General Hospital Kuala Lumpur: A 5-year Retrospective 
Study.  
Chan Chee Kong1, 2, Saffari Haspani2, Zamzuri Idris1   
 
1Centre for Neuroscience Services and Research as Department of Neuroscience, School of 
Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. 
2Department of Neurosurgery, Hospital Kuala Lumpur (HKL), Wilayah Persekutuan Kuala 
Lumpur, Malaysia. 
 
Background: Meningiomas are the most common intracranial tumours, accounting for 13-26% of 
all the primary intracranial tumours.  In the United States, an estimated 2–3% of the population 
has an incidental asymptomatic meningioma, and annual incidence of symptomatic meningioma 
is 2 cases per 100,000 individuals. Skull base meningiomas comprise 30% of meningiomas and 
are one of the most difficult intracranial tumours to be managed surgically because of the 
difficulty in approaching the lesions and their proximity to vital structures such as cranial nerves 
and major blood vessels. Meningiomas are commonly seen in Malaysia, however there is 
minimal local data published. The main purpose of our study was to identify the demographic 
data, tumours characteristic and surgical outcome of patients with meningiomas operated in 
GHKL. 
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Methods: A total of 199 patients with histologically proven meningiomas were operated from 
January 2010 till December 2014 in General Hospital Kuala Lumpur.  They were categorized 
into skull base and non-skull base groups. Demographical data, tumour characteristics and 
patients’ outcome were studied. Kaplan-Meier overall survival curve and Cox hazard univariable 
and multivariable regression for possible predictors of survival were analyzed.  
 
Results: There was 199 patients included in the study, 97.5% of the patients (n=194) had WHO 
grade I meningioma Only 5 patients had WHO grade II meningiomas. However, no new WHO 
grade III meningiomas diagnosed throughout the study period. Majority of our patients were 
female (n=134; 67.3%) with only 65 patients were male (32.7%).  Malay ethnicity has the 
highest incidence (n=138; 69.3%).  
Skull base meningioma (n=54) comprised 27.1 % of all the intracranial meningioma. Majority of 
the skull base meningiomas were histopathologically WHO grade I (n=52, 96.3%).  Seventy 
percent of the skull base meningioma group was female (n=38) with mean age at diagnosis was 
51.7 (SD 11.01), as compared to non-skull base group with mean age of diagnosis at 54.1 (SD 
9.4). Both categories showed highest prevalence in age group 40-60 with skull base group (n=33; 
61.1%) and non-skull base group (n=91; 62.8%). Majority of the patients in both skull base and 
non-skull base group presented with clinical feature of headache, with 94.4% (n=51) and 91% 
(n=132) respectively. Radiologically, ninety four percent of the patients with skull base 
meningioma (n=51) had radiological evidence of oedema; 30 cases (55.6%) had hyperotosis and 
16 patients (29.6%) had calcification as reported by radiologists.  
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Skull base meningioma was related to poorer outcome with poor discharge condition (n=23; 
42.6% p value < 0.01) and higher possibility of incomplete resection (n=34; 63% p value < 0.01). 
In contrast, 88% (n=128) patients in non-skull base meningiomas group were discharged well 
and only 11 cases out of the total 145 patients were incompletely resected. Our study showed a 
shorter median survival of 37.6 months (SD 20.94) for skull base group as compared to 47.8 
months (SD 18.2) in the non-skull base group with p-value 0.187.  
Multivariate cox hazard regression test showed skull base meningioma group had 4 times the 
chance to succumb to death as compared to non-skull base group (Adjusted HR 4.22; 95% CI 
1.53-11.66; p-value 0.005), adjusted with gender, comorbidities, WHO grading and extends of 
meningioma.  
Conclusion: The primary treatment for symptomatic meningioma is surgery, which can be 
curative if the tumour is completely removed. Skull base meningiomas are widely accepted as 
being more technically challenging to achieve gross total resection. Our study has showed skull 
base meningiomas operated locally had higher rate of incomplete resection and poorer surgical 
outcome as compared to non-skull base group.  Patients with skull base meningioma had 4 times 
higher risk to succumb to death as compare to non-skull base group. More studies need to be 
carried out locally to look into skull base meningioma seriously for the improvement of surgical 
outcome. 
Key words: Meningiomas, skull base, WHO, clinical feature, Kaplan Meier survival curve, 
predictor, outcome. 
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Introduction and Literature review  
Meningiomas are the most common non-glial primary intracranial tumour. (1) Hospital-based 
brain tumour series indicate that the incidence of meningiomas is approximately 20% of all 
intracranial tumours, whereas autopsy-based studies indicate an overall incidence of 30%.(1, 2) 
Meningiomas occur with an annual population incidence of 6.0 per 100,000 persons per year, 
and have recently surpassed gliomas as the most common primary brain and central nervous 
system tumour in the United State, accounting for 36.8% of all tumour (2). Fonkem et al (2016) 
reported the incidence among females is shown to be 2.3 times that of males (3).  
 
Yusoff et al reported the incidence of brain tumour among Kelantan and Terengganu Population 
in 1996 was 0.44 per 100,000 population per year. (4, 5) Report of National Cancer Registry 
(2007) revealed that the crude incidence of brain tumour and nervous system including spine and 
peripheral nervous tumour was 2.0 for male and 1.7 for female per 100,000 population per year.  
(6) Globocan 2012 estimated Malaysia brain tumours and other nervous system age standardized 
incidence to be 2.8 per 100,000 population per year with cumulative rate 0.3%. (7) Two 
prospective studies by General Hospital Sarawak Neurosurgical unit published in 2002 and 2014 
showed an average two meningiomas case were done a month (8) and thirty to thirty five percent 
of the operated cases were meningiomas (4, 8). General Hospital Kuala Lumpur (GHKL), being 
our national neurosurgical referral center in Peninsular Malaysia, has been providing 
neurosurgical services for many years. The main purpose of our study was to identify the 
demographic data of the patients with meningiomas and were operated in GHKL. Besides, the 
tumour characteristics, radiological features and surgical outcome would be studied as well. 
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Meningiomas of the cranial base account for approximately 25% of all meningiomas, with a 
reported ratio of calvarial-to-skull base distribution of 2.3:1. (9) Skull base meningiomas are 
difficult to be managed surgically because of the difficulty in approaching the lesions and their 
proximity to vital structures such as cranial nerves and major blood vessels. (9, 10) Literature 
reviews showed skull base meningioma is more surgically demanding and challenging (10, 11). 
Many countries have developed skull base neurosurgery as a distinct neurosurgery subspecialty 
(10).  
 
Previous two local prospective studies to-date from General Hospital Sarawak lacked grouping 
of meningiomas into skull base and non-skull base for comparison. (4, 8). It is therefore 
important to establish the prevalence in local settings and to analyze skull base meningiomas 
versus non-skull base in term of demographic data, radiological features and surgical outcome. 
Only with local data available, we could compare ours with other international studies available. 
These helps in identifying any possible factors affecting the surgical outcome especially, for the 
betterment of neurosurgical care in Malaysia. 
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Study Protocol 
i. Ethical approval letter 
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ii. Amendment from approved of study protocol and its justification 
- Small amendment was performed to modify the study title to ‘comparison on Incidence, 
Radiological Features and Outcome of Skull base versus Non-skull base meningiomas in 
General Hospital Kuala Lumpur: A 5-year Retrospective Study’ after discussed with 
consultant neurosurgeons during 6 monthly assessments, in view the progress in data 
collection in single hospital was convincing. The main purpose of the study was to 
emphasize on the incidence of meningioma in Malaysia as well as its radiological 
features and surgical outcome, comparison between two neurosurgical centers has 
minimal added value over the prevalence and outcome of meningioma in Malaysia as a 
whole. Besides, grouping meningiomas based on location- skull base versus non-skull 
base highlighted the purpose of the study which was to explore, and hopefully to 
establish the need for subspecialty in skull base neurosurgery in Malaysia, as literature 
reviews showed skull base meningioma is surgically more demanding and challenging.  
- Aim to include multicenter for data collection was initiated, however, due to time 
constraints, was advised to continue data collection in multicenter neurosurgical centers 
later as phase II study. Amendment for title modification was sent to NMRR and 
approved. 
 
 
 
 
 
 
17 
 
Body 
Abstract 
a. Article title 
Comparison on Incidence, Radiological Features and Outcome of Skull Base Versus Non-
skull Base meningiomas in General Hospital Kuala Lumpur: A 5-year Retrospective Study.  
Chan Chee Kong1, 2, Saffari Haspani2, Zamzuri Idris1   
 
1Centre for Neuroscience Services and Research as Department of Neuroscience, School of 
Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. 
2Department of Neurosurgery, Hospital Kuala Lumpur (HKL), Wilayah Persekutuan Kuala 
Lumpur, Malaysia. 
 
Background: Meningiomas are the most common intracranial tumours, accounting for 13-26% of 
all the primary intracranial tumours.  In the United States, an estimated 2–3% of the population 
has an incidental asymptomatic meningioma, and annual incidence of symptomatic meningioma 
is 2 cases per 100,000 individuals. Skull base meningiomas comprise 30% of meningiomas and 
are one of the most difficult intracranial tumours to be managed surgically because of the 
difficulty in approaching the lesions and their proximity to vital structures such as cranial nerves 
and major blood vessels. Meningiomas are commonly seen in Malaysia, however there is 
minimal local data published. The main purpose of our study was to identify the demographic 
data, tumours characteristic and surgical outcome of patients with meningiomas operated in 
GHKL. 
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Methods: A total of 199 patients with histologically proven meningiomas were operated from 
January 2010 till December 2014 in General Hospital Kuala Lumpur.  They were categorized 
into skull base and non-skull base groups. Demographical data, tumour characteristics and 
patients’ outcome were studied. Kaplan-Meier overall survival curve and Univariate and 
Multivariate Cox hazard regression for possible predictors of survival were analyzed.  
 
Results: There were 199 patients included in the study, 97.5% of the patients (n=194) had WHO 
grade I meningioma Only 5 patients had WHO grade II meningiomas. However, no new WHO 
grade III meningiomas diagnosed throughout the study period. Majority of our patients were 
female (n=134; 67.3%) with only 65 patients were male (32.7%).  Malay ethnicity has the 
highest incidence (n=138; 69.3%).  
Skull base meningioma (n=54) comprised 27.1 % of all the intracranial meningioma. Majority of 
the skull base meningiomas were histopathologically WHO grade I (n=52, 96.3%).  Seventy 
percent of the skull base meningioma group was female (n=38) with mean age at diagnosis was 
51.7 (SD 11.01), as compared to non-skull base group with mean age of diagnosis at 54.1 (SD 
9.4). Both categories showed highest prevalence in age group 40-60 with skull base group (n=33; 
61.1%) and non-skull base group (n=91; 62.8%). Majority of the patients in both skull base and 
non-skull base group presented with clinical feature of headache, with 94.4% (n=51) and 91% 
(n=132) respectively. Radiologically, ninety four percent of the patients with skull base 
meningioma (n=51) had radiological evidence of oedema; 30 cases (55.6%) had hyperotosis and 
16 patients (29.6%) had calcification as reported by radiologists.  
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Skull base meningioma was related to poorer outcome with poor discharge condition (n=23; 
42.6% p value < 0.01) and higher possibility of incomplete resection (n=34; 63% p value < 0.01). 
In contrast, 88% (n=128) patients in non-skull base meningiomas group were discharged well 
and only 11 cases out of the total 145 patients were incompletely resected. Our study showed a 
shorter median survival of 37.6 months (SD 20.94) for skull base group as compared to 47.8 
months (SD 18.2) in the non-skull base group with p-value 0.187.  
Multivariate cox hazard regression test showed skull base meningioma group had 4 times higher 
risk to succumb to death as compared to non-skull base group (Adjusted HR 4.22; 95% CI 1.53-
11.66; p-value 0.005), adjusted with gender, comorbidities, WHO grading and extends of 
meningioma.  
Conclusion: The primary treatment for symptomatic meningioma is surgery, which can be 
curative if the tumour is completely removed. Skull base meningiomas are widely accepted as 
being more technically challenging to achieve gross total resection. Our study has showed skull 
base meningiomas operated locally had higher rate of incomplete resection and poorer surgical 
outcome as compared to non-skull base group.  Patients with skull base meningioma had 4 times 
higher risk to succumb to death as compare to non-skull base group. More studies need to be 
carried out locally to look into skull base meningioma seriously for the improvement of surgical 
outcome. 
Key words: Meningiomas, skull base, WHO, clinical feature, Kaplan Meier survival curve, 
predictor, outcome. 
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Introduction 
Meningiomas are the most common non-glial primary intracranial tumour. (1) Hospital-based 
brain tumour series indicate that the incidence of meningiomas is approximately 20% of all 
intracranial tumours, whereas autopsy-based studies indicate an overall incidence of 30%.(1, 2) 
Meningiomas occur with an annual population incidence of 6.0 per 100,000 persons per year, 
and have recently surpassed gliomas as the most common primary brain and central nervous 
system tumour in the United State, accounting for 36.8% of all tumour (2). Fonkem et al (2016) 
reported the incidence among females is shown to be 2.3 times that of males (3).  
 
Yusoff et al reported the incidence of brain tumour among Kelantan and Terengganu Population 
in 1996 was 0.44 per 100,000 population per year. (4, 5) Report of National Cancer Registry 
(2007) revealed that the crude incidence of brain tumour and nervous system including spine and 
peripheral nervous tumour was 2.0 for male and 1.7 for female per 100,000 population per year.  
(6) Globocan 2012 estimated Malaysia brain tumours and other nervous system age standardized 
incidence to be 2.8 per 100,000 population per year with cumulative rate 0.3%. (7) Two 
prospective studies by General Hospital Sarawak Neurosurgical published in 2002 and 2014 
showed an average two meningiomas case were done a month (8) and thirty to thirty five percent 
of the operated cases were meningiomas (4, 8). General Hospital Kuala Lumpur (GHKL), being 
our national neurosurgical referral center in Peninsular Malaysia, has been providing 
neurosurgical services for many years. The main purpose of our study was to identify the 
demographic data of the patients with meningiomas and were operated in GHKL. Besides, the 
tumour characteristics, radiological features and surgical outcome would be studied as well. 
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Meningiomas of the cranial base account for approximately 25% of all meningiomas, with a 
reported ratio of calvarial-to-skull base distribution of 2.3:1. (9) Skull base meningiomas are 
difficult to be managed surgically because of the difficulty in approaching the lesions and their 
proximity to vital structures such as cranial nerves and major blood vessels. (9, 10) Literature 
reviews showed skull base meningioma is more surgically demanding and challenging (10, 11). 
Many countries have developed skull base neurosurgery as a distinct neurosurgery subspecialty 
(10).  
 
Previous two local prospective studies to-date from General Hospital Sarawak lacked grouping 
of meningiomas into skull base and non-skull base for comparison. (4, 8). It is therefore 
important to establish the prevalence in local settings and to analyse skull base meningiomas 
versus non-skull base in term of surgical outcome. Only with local data available, we could 
compare ours with other international studies available. These helps in identifying any possible 
factors affecting the surgical outcome, for the betterment of neurosurgical care in Malaysia. 
 
Methodology: 
Patient population and initial evaluation 
A retrospective review of all intracranial tumour patients operated in Neurosurgical Department 
General Hospital Kuala Lumpur from January 2010 to December 2014 was carried out and all 
operated meningioma cases were identified. We analyzed the demographic data, radioimaging 
reports (in the form of initial X-rays, CT Scans, and MRI), histopathological findings, surgical 
outcome and follow-up review in the patients’ medical records. Inclusion criteria were newly 
diagnosed meningiomas operated between the study periods and was histo-pathologically proven 
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according to World Health Organization (WHO) Grading system 2007 and 2016. (12, 13) 
Exclusion criteria includes recurrent meningiomas, extracranial meningioma and patients with 
incomplete data or records.   
 
Grouping 
Patient with meningiomas operated were divided into skull base and non-skull base group, based 
on their tumour location as listed by Brokinkel et al. 2012 for skull base group. (1, 9, 14-16). 
Skull base meningiomas included olfactory groove (n=15), sphenoid ridge (n=22), tuberculum 
sellae or sellar (n=4), cerebellopontine angle (n=8) and petroclival or clivus (n=5). Non-skull 
base meningiomas (n=152) included convexity, falx, parasagittal, supra-tentorial and infra-
tentorial meningiomas apart from skull base locations. 
 
Imaging characteristics 
The MRI and CT brain reports by radiologists were reviewed. Maximal diameter of meningioma 
documented was used to indicate the size of the tumour. (8, 17) ABC/2 was conducted as follows: 
A= maximum tumour diameter, B= diameter of the tumour perpendicular to A, and C= 
maximum height of the tumours as reported on MRI scan or CT scan (17). Besides, other 
radiological features as reported by the radiologists such as presence of oedema, hyperotosis and 
calcification for meningiomas were reviewed, as suggested by Ben et al (2016). (18) 
 
Surgical and pathological review 
Operative notes and both pre- and post-operative imaging were reviewed to determine the 
tumour characteristics and completeness of resection as per Simpsons grading. The extents of 
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resection were classified as gross total resection (GTR) or subtotal resection (STR) 
corresponding to EORTC/RTOG definition as related to Simpson 1-3 and Simpsons 4 
respectively, as been quoted in Jenkinson et al. 2015. (19, 20) Besides, GTR was defined as no 
intraoperative evidence of residual tumour and no evidence of residual tumour and no evidence 
of contrast enhancement on post-operative scan. (19, 20) When either of these criteria was not 
satisfied, the extent of surgery was classified as subtotal. (20) 
All meningiomas were graded as per World Health Organization (WHO) histopathological grade. 
(12, 13) 
 
Outcome of surgery 
Surgery was the sole modality of treatment. Post-operative complications including those 
required re-surgery reviewed. Functional outcome was categorized as well, partially dependent, 
fully dependent and death post-surgical intervention and follow-up based on Modified Rankin 
Scale. (11, 21)  
 
Follow-up 
The periods between the first complaints and diagnosis was registered as symptoms duration. 
Follow-up MRS data were collected through clinical records in 3 months, 6 months, 12 months 
and 18 months thereafter. (21) Overall survival (OAS) was calculated from the date of diagnosis 
to the date of death or the last follow-up for survival analysis. (9, 22, 23) 
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Statistical Analysis 
Descriptive analysis was performed using Strata version 22 and SPSS version 24. Categorical 
data were expressed as proportions while continuous data were presented in mean ± Standard 
deviation (SD). Gender differences and age were assessed using α test and Student’s t-test, 
respectively. Tumour maximum diameter and calculated tumour volume were represented as 
mean ± SD. Overall survival (OAS) was calculated from the date of diagnosis to the date of 
death or last follow-up,  Kaplan Meier survival curve were plotted to estimate the survival. (24) 
Univariable and multivariable cox regression analysis was used to identify predictors for poor 
outcome.  P-value of < 0.05 is considered significant. 
 
Results: 
Descriptive analysis prior grouping 
A total of 1149 intracranial brain tumour cases were operated from January 2010 and December 
2014. 199 patients were newly diagnosed meningioma and these patients were recruited. 
Majority of the patients had WHO grade I meningioma (n=194, 97.5%) and only 5 patients had 
WHO grade II meningioma. No newly diagnosed WHO grade III meningioma patients during 
the study period. Female predominated (n=134; 67.3%) with 2: 1 ratio to male. Malay was most 
commonly affected race (n=138; 69%). Highest incidence at age group 40-60 years noted (n=124; 
62.3%).  
 
 
